Artiva Biotherapeutics (ARTV) EBT (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported EBT of -$23.5 million for Q1 2026, down 15.81% year-over-year from -$27.9 million in Q1 2025, and down 13.23% quarter-over-quarter from -$20.8 million in Q4 2025.
Artiva Biotherapeutics (ARTV) EBT (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of EBT data on file, last reported at -$23.5 million in Q1 2026.
- EBT for Q1 2026 came in at -$23.5 million, down 15.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.1 million (down 27.28% YoY), and the FY2025 annual result was -$83.9 million, down 28.27% from the prior year.
- EBT retreated to -$23.5 million in Q1 2026 per ARTV's latest filing, from -$20.8 million in the prior quarter.
- Over five years, EBT peaked at $13.3 million in Q4 2023 and troughed at -$23.5 million in Q1 2026.
- A 4-year average of -$13.0 million and a median of -$16.3 million in 2024 frame the typical range for EBT.
- The sharpest annual moves came in 2024 and 2026: EBT tumbled 246.84% in 2024, then decreased 15.81% in 2026.
- A 4-year view of EBT shows it stood at $13.3 million in 2023, then sank by 221.42% to -$16.1 million in 2024, then declined by 29.09% to -$20.8 million in 2025, then slipped by 13.23% to -$23.5 million in 2026.
- Business Quant data shows ARTV's EBT at -$23.5 million in Q1 2026, -$20.8 million in Q4 2025, and -$21.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.52 Mn |
| Dec 31, 2025 | -20.77 Mn |
| Sep 30, 2025 | -21.53 Mn |
| Jun 30, 2025 | -21.25 Mn |
| Mar 31, 2025 | -20.31 Mn |
| Dec 31, 2024 | -16.09 Mn |
| Sep 30, 2024 | -16.49 Mn |
| Jun 30, 2024 | -15.51 Mn |
| Mar 31, 2024 | -13.84 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 11.23 Mn |
| Jun 30, 2023 | -11.32 Mn |